Argus
•
Sep 02, 2026
VCYT: What does Argus have to say about VCYT?
Summary
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Illumina Inc
Sep 03, 2026
•
ILMN
Analyst Report: Qiagen N.V.
Sep 03, 2026
•
QGEN
Market Digest: ILMN, SLF, PANW, AXON
Sep 03, 2026
•
ILMN, AXON, SLF, PANW
XNCR: Lowering target price to $29.00
Sep 02, 2026
•
XNCR
Market Update: HLF, LH, WWW
Aug 31, 2026
•
HLF, WWW, LH
